Patterns in Utilization of Healthcare Services and Medications among Patients with Cutaneous Immune-Related Adverse Events - Supplemental Materials

Published: 13 January 2023| Version 1 | DOI: 10.17632/gdwdcsm5z9.1
Contributor:
Bonnie Leung

Description

Supplemental Methods and Supplemental Table 1: Number of instances of systemic steroid and outpatient visit utilizations among patients who developed cutaneous immune-related adverse events.

Files

Institutions

Brigham and Women's Hospital, Massachusetts General Hospital

Categories

Dermatology, Oncology, Immune Checkpoint Inhibitor

Licence